Oklahoma City biotech startup seeks funding for clinical trials

Oklahoma City’s EpimedX trying to develop treatment for sickle cell disease, which affects more than 90,000 people in the United States.

BY BRIANNA BAILEY Published: January 10, 2013

Local biotech startup EpimedX believes a drug known as Edx-17 could help treat annually more than 90,000 patients with sickle cell disease in the United States.

“Sickle cell disease...

Oklahoman subscribers have access to this article. Unlock it below.

What is this? Learn more.
NewsOK.com has disabled the comments for this article.